Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 May 22;27(8):899–907. doi: 10.1158/1055-9965.EPI-17-1174

Table 3.

Odds ratios for breast cancer among cancer patients who either have AML or breast cancer by the presence or absence of point mutations in driver genes that either are, or are not, regulated by E2-ESR1.

AML
Breast Cancer
Odds Ratio P Value 95% Confidence Interval
Number (%) Number (%)
No mutations in regulated genes* 228 (16.3) 8 (1.7) 1.0
At least one mutation in regulated genes* 1,175 (83.7) 470 (98.3) 11.4 2.9×10−22 6.0 ‒ 25

Total 1,403 (100) 478 (100)
No mutations in unregulated genes 419 (29.9) 330 (69.0) 1.0
At least one mutation in unregulated genes 984 (70.1) 148 (31.0) 0.191 3.4×10−51 0.15 ‒ 0.24

Total 1,403 (100) 478 (100)
At least one mutation in unregulated genes 984 148 1.0
At least one mutation in regulated genes* 1,175   470   22.4 2.4×10−17 11 ‒ 46
*

Genes regulated by E2-ESR1

Genes not regulated by E2-ESR1

Denominator of following odds ratio